Mostrando 4 resultados de: 4
Filtros aplicados
Publisher
Current Drug Targets(1)
Drug Metabolism and Drug Interactions(1)
Journal of Psychopharmacology(1)
Pharmacogenomics(1)
Área temáticas
Farmacología y terapéutica(4)
Enfermedades(3)
Fisiología humana(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Problemas sociales y servicios a grupos(1)
Origen
scopus(4)
Pharmacogenetics of clinical response to risperidone
ReviewAbstract: Despite risperidones proven safety and efficacy, existing pharmacogenetic knowledge could be appliedPalabras claves:Biomarkers, Clinical outcome, pharmacogenetics, Risperidone, side effectsAutores:Adrián LLerena, Berecz R., Humberto Fariñas, Penãs-Lledó E.M., Süveges A.Fuentes:scopusLiver enzyme abnormalities during antipsychotic treatment: A case report of risperidone-associated hepatotoxicity
ArticleAbstract: Background: Drug-induced liver enzyme abnormalities may indicate hepatic injury. Antipsychotic drugsPalabras claves:CYP2D6, Hepatotoxicity, Liver enzymes, RisperidoneAutores:Adrián LLerena, Berecz R., Doña A., Dorado P., López-Torresa E., Penãs-Lledó E.M., Süvegesa A.Fuentes:scopusQTc interval, CYP2D6 and CYP2C9 genotypes and risperidone plasma concentrations
ArticleAbstract: The role of certain drug metabolizing enzymes in cardiotoxicity, such as CYP2D6 for thioridazine, haPalabras claves:9-hydroxy-risperidone, CYP2C9, CYP2D6, QTc, RisperidoneAutores:Adrián LLerena, Berecz R., De La Rubis A., Dorado P.Fuentes:scopusThe role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions
ReviewAbstract: In the recent years it has been increasingly recognized that pharmacogenetical factors play an imporPalabras claves:CYP2D6, CYP3A4, metabolism, pharmacogenetics, RisperidoneAutores:Adrián LLerena, Berecz R., Cáceres M.C., De la Rubia A., Degrell I., Dorado P.Fuentes:scopus